Part B Insider - 2003 Issue 17
Want To Put In Your Two Cents On Eye Therapy? Here's Your Chance
Subscribe or sign in to view the full article.
Article Overview
This short article summarizes a Medicare coverage review item involving ocular photodynamic therapy with verteporfin and notes the related public comment process, meeting schedule, and Federal Register notice. It is relevant to ophthalmology, medical coding, and reimbursement professionals who track Medicare coverage activity and coverage policy updates.
Why This Topic Matters
Medicare coverage review activity can affect reimbursement and documentation considerations for services used in ophthalmology. This notice helps readers identify an upcoming policy discussion and the timeframe for submitting input.
What You Will Learn
- What Medicare coverage review activity is being announced
- Which specialty area the notice relates to
- What the article says about the timing of the committee meeting and comment deadline
- How the notice may matter for reimbursement-related monitoring
Who Should Read This
- Medical coders
- Billing specialists
- Ophthalmology practices
- Compliance staff
- Reimbursement analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com